当前位置: X-MOL 学术J. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Non-seminomatous Germ-Cell Tumor.
The Journal of Urology ( IF 6.6 ) Pub Date : 2022-06-08 , DOI: 10.1097/ju.0000000000002751
Jennifer M King 1 , Sandra Althouse 2 , Clint Cary 3 , Timothy Masterson 3 , Richard S Foster 3 , Ryan Ashkar 3 , Nasser H Hanna 1 , Lawrence H Einhorn 1 , Nabil Adra 1
Affiliation  

The optimal management of patients with metastatic germ cell tumors (GCTs) who achieve a complete response (CR) after first-line chemotherapy remains unsettled. This study reports long-term outcomes of patients with GCT managed with surveillance after achieving a CR to first-line chemotherapy.

中文翻译:

转移性非精原细胞生殖细胞肿瘤患者对一线化疗完全反应后的监测。

一线化疗后达到完全缓解 (CR) 的转移性生殖细胞肿瘤 (GCT) 患者的最佳管理仍未确定。本研究报告了 GCT 患者在一线化疗达到 CR 后接受监测管理的长期结果。
更新日期:2022-06-08
down
wechat
bug